Personalized Treatment for Eating Disorders
(T-NIPT-ED Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to develop a personalized treatment for eating disorders (EDs) that considers each person's unique situation and social context. Researchers will compare a new personalized approach, Transdiagnostic Network Informed Personalized Treatment (T-NIPT-ED), with the current gold-standard treatment, Cognitive Behavioral Therapy Enhanced (CBT-E), to determine which is more effective. The trial seeks participants with an active eating disorder diagnosis, such as anorexia nervosa or other specified feeding or eating disorders, but not Avoidant/Restrictive Food Intake Disorder (ARFID). Participants should not have active suicidality, mania, or psychosis. As an unphased trial, this study offers participants the chance to contribute to pioneering research that could lead to more effective, personalized treatments for eating disorders.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that Enhanced Cognitive Behavioral Therapy for Eating Disorders (CBT-E) is generally safe. It has proven effective, particularly for bulimia nervosa and binge eating disorder. Most patients tolerate CBT-E well, with no major safety concerns reported in studies.
Early studies on Transdiagnostic Network Informed Personalized Treatment (T-NIPT-ED) suggest it is also safe. This new method uses personal data to tailor treatment and has shown promise in improving recovery rates. Initial trials have noted no significant safety issues.
Both treatments appear well-tolerated, with few side effects reported. Safety remains a top priority in research, and these treatments have shown promise in that area.12345Why are researchers excited about this trial?
Researchers are excited about these treatments for eating disorders because they offer a personalized approach. Unlike standard therapies like Cognitive Behavioral Therapy (CBT) alone, the Transdiagnostic Network Informed Personalized Treatment tailors sessions based on real-time data from participants' daily experiences, making the treatment more individualized. This approach is expected to address the unique needs of each patient more effectively, potentially improving outcomes by focusing on the specific patterns and triggers that contribute to their eating disorder.
What evidence suggests that this trial's treatments could be effective for eating disorders?
This trial will compare Enhanced Cognitive Behavioral Therapy for Eating Disorders (CBT-E) with Transdiagnostic Network Informed Personalized Treatment. Research has shown that CBT-E effectively treats various eating disorders, particularly bulimia nervosa and binge eating disorder, leading to significant patient improvements. Despite its proven benefits, CBT-E remains underutilized.
In contrast, the Transdiagnostic Network Informed Personalized Treatment, which participants in this trial may receive, is a newer approach. Early results from pilot studies suggest it could be effective by focusing on each patient's individual needs and specific treatment methods, such as reducing feelings of shame. This personalized approach aims to provide more tailored treatment, potentially improving outcomes for people with eating disorders by considering the unique factors affecting each person.34567Who Is on the Research Team?
Cheri A Levinson, PhD
Principal Investigator
University of Louisville
Are You a Good Fit for This Trial?
This trial is for adults aged 18-65 with an active eating disorder, excluding ARFID. It's not suitable for individuals who are currently experiencing suicidal thoughts, mania, or psychosis.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Phase I: Ecological Momentary Assessment
Participants undergo two weeks of ecological momentary assessment to characterize individual mechanisms of treatment
Phase II: Treatment
Participants receive 10 sessions of either Enhanced Cognitive Behavioral Therapy for Eating Disorders (CBT-E) or personalized treatment based on ecological momentary assessment surveys
Relapse Prevention
Participants complete one session of relapse prevention at the end of the treatment phase
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Enhanced Cognitive Behavioral Therapy for Eating Disorders
- Transdiagnostic Network Informed Personalized Treatment
Enhanced Cognitive Behavioral Therapy for Eating Disorders is already approved in United States, European Union for the following indications:
- Anorexia Nervosa
- Bulimia Nervosa
- Binge Eating Disorder
- Other Specified Feeding or Eating Disorder
- Anorexia Nervosa
- Bulimia Nervosa
- Binge Eating Disorder
- Other Specified Feeding or Eating Disorder
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Louisville
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator